You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Online First: January 2, 2012 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Article
 •Online Features
 This Article
 •Full text
 •PDF
 •eSupplement
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Cognitive Disorders
 •Psychiatry
 •Psychiatry, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

ONLINE FIRST
Self-reported Attenuated Psychotic Symptoms as Forerunners of Severe Mental Disorders Later in Life

Nomi Werbeloff, PhD; Marjan Drukker, PhD; Bruce P. Dohrenwend, PhD; Itzhak Levav, MD; Rinat Yoffe, MA; Jim van Os, MD, PhD; Michael Davidson, MD; Mark Weiser, MD

Arch Gen Psychiatry. Published online January 2, 2012. doi:10.1001/archgenpsychiatry.2011.1580

Context  It has been suggested that attenuated psychotic symptoms (APSs) reported by people who do not have psychotic disorders signal risk for later severe mental illness.

Objective  To investigate this suggestion using follow-up assessments of hospitalization for clinical diagnoses of nonaffective psychotic and other psychiatric disorders.

Design  Longitudinal cohort study of self-reported APSs with outcome assessment of severe mental illness obtained through linkage with a national hospitalization case registry.

Setting  Israel.

Participants  A stratified full probability sample of 4914 persons aged 25 to 34 years who were screened for psychopathology in the 1980s.

Main Outcome Measure  Subsequent psychiatric hospitalization was ascertained using the psychiatric hospitalization registry, with a mean follow-up of 24 years.

Results  After removing subjects with diagnosable psychotic disorders at baseline, 57.2% of the remaining sample reported at least 1 weak (infrequent) APS and 14.3% reported at least 1 strong (frequent) APS in the year preceding the assessment. Self-reported APSs predicted risk of later hospitalization for nonaffective psychotic disorders, mostly during the 5 years after baseline (adjusted odds ratio = 4.31; 95% CI, 2.21-8.41; positive predictive value = 1.27%; population attributable risk fraction = 33%). Also, APSs increased the risk of later hospitalization for other psychiatric disorders, albeit to a lesser extent (adjusted odds ratio = 2.21; 95% CI, 1.02-4.82).

Conclusions  Self-reported APSs signal risk for later nonaffective psychotic disorders but are not clinically useful as predictors. The difference between these population-based data and the high-risk literature in terms of the positive predictive value (1% vs 10%, respectively) and the time window of transition (5 years vs 12 months, respectively) can be attributed to the selective enrichment strategies that produce high-risk samples.


Author Affiliations: Department of Psychiatry, Sheba Medical Center, Tel Hashomer (Drs Werbeloff, Davidson, and Weiser), Division of Mental Health Services, Ministry of Health, Jerusalem (Dr Levav and Ms Yoffe), and Department of Psychiatry, Sackler School of Medicine, Tel Aviv University, Ramat Aviv (Drs Davidson and Weiser), Israel; Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, European Robotics Research Network, Maastricht University Medical Centre, Maastricht, the Netherlands (Drs Drukker and van Os); Department of Psychiatry, Mailman School of Public Health, Columbia University, New York State Psychiatric Institute, New York (Dr Dohrenwend); and Department of Psychosis Studies, Institute of Psychiatry, King's College London, King's Health Partners, London, England (Dr van Os).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2012 American Medical Association. All Rights Reserved.